OR WAIT null SECS
Transferring Energy to Hot Melt Extrusion
A greater understanding of molecular and cellular biology and technological advancements are revolutionizing the field of biologics.
The use of appropriate taste-masking and appearance technologies can facilitate patient compliance.
A comparison between polysorbates and HPβCD determines the better stabilizer for biologics formulation.
This study reviews changes in in-country testing (registration testing, import testing) requirements and analyzes current trends.
Guidance documents and interaction with FDA can help manufacturers stay in GMP compliance, says Siegfried Schmitt, VP Technical, at Parexel.
A Closer Look at mRNA in Oncology and Vaccines
May 07, 2024
ProPharm and PBL have introduced a fully automated, enclosed cell factory manufacturing device.
The two companies will combine their cell therapy platforms to develop convertibleCAR programs targeting solid tumors.
May 06, 2024
The request for more information was received weeks after an application to the FTC was refiled to approve the deal.
May 05, 2024
May 04, 2024
A new draft guidance issued by FDA covers human- and animal-derived materials used in the manufacture of advanced therapy medicinal products.
May 03, 2024
Cormica’s first US Acquisition is intended to support to organic growth of TPM laboratories.
The loan is intended to support Ennogen’s growth as it looks to international acquisitions.
In this exclusive Drug Digest video interview, Chris Spivey, Director, Industry Relations and Strategic Partnerships, talks with industry experts about various aspects of drug product stability testing.
Technological advances are helping advance biologics development and manufacturing and reduce bottlenecks.